Astex Pharmaceuticals is supplying the technology that allows AstraZeneca to develop it.
A Lot of Promising Candidates
With the help of Astex Pharmaceuticals (Nasdaq:ASTX), AstraZeneca (NYSE:AZN) is working on AZD-3839 - a drug that blocks the enzyme that may ultimately induce Alzheimer's. AstraZeneca owns the drug; Astex Pharmaceuticals is supplying the technology that allows AstraZeneca to develop it. It's called "Pyramid," and it's not only being used by AstraZeneca to develop this drug, but by several other companies looking to develop other small molecule therapies ... now that they can.
Did you happen to review the actual trial? Interesting that it was completed in early 2012 and Astra zeneca hasn't moved it forward in over a year. This is why you have to be careful with this board, this is the same guy predicting $15 and now posting a drug that Astra Zenca dropped. Look three readers flag this as thumbs up. Meaning none of them actually research, if this info was true. You have another poster stating that the shorts made a profit on the stock rising.
Well it's headed to $15 and they advancing a drug that they dropped.
It's almost like I don't have to support my points, the current longs do the job for you. Tuesday morning reality hits. Specially when the focus will be costs rising and Dacogen generic impact.
Bucket is a trader who claims he sold and then stays on a msg. to convince others to sell when the stock share price continues to move forward and institutions continue to accumulate. Don't forget upgrades with share price target of $9.